April 2016 – AIM new arrivals and departures
Following a more active March, April proved to be another quiet month for new issue activity on AIM with only 2 genuine new arrivals but several re-admissions, a couple of which were particularly interesting. May offers more promise, with several interesting IPOs on the slate, including the fascinating Hotel Chocolat, which we issued a commentary on last week. Our updated AIMsearch search tool offers guidance on which AIM companies benefit from the valuable tax benefits. For more on the latest admissions, read on.
At the end of April 2016 there were 1,013 companies on AIM with a total market value of £72.98bn. This compares with 1,020 companies on AIM at the end of March 2016 when the market value was £70.76bn. The quantity continues to decline but the quality improves! Here are the highlights, with The Brighton Pier Group capturing most investor’s attention! Amryt Pharma (AIM:AMYT) is a specialty pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. The Group arrived on AIM following the reversal into the previously named…